Pharmaceutical distributors and attorneys general in 39 states are among several entities that have objected to a proposal aimed at reaching a nationwide settlement of legal claims over the opioid crisis.

The objections, filed Tuesday, potentially thwart court approval of an unprecedented idea floated by lead plaintiffs attorneys in the multidistrict litigation over opioids. Among the objectors were pharmaceutical distributors and pharmacies, which, in a combined court filing, said there were too many unknowns about the proposal, which plaintiffs attorneys amended earlier this month in an attempt to garner more support.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]